Genedrive PLC
LSE:GDR
Balance Sheet
Balance Sheet Decomposition
Genedrive PLC
Current Assets | 3.2m |
Cash & Short-Term Investments | 1.2m |
Receivables | 1.4m |
Other Current Assets | 539k |
Non-Current Assets | 279k |
PP&E | 279k |
Current Liabilities | 1.9m |
Accounts Payable | 788k |
Other Current Liabilities | 1.1m |
Balance Sheet
Genedrive PLC
Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
4
|
4
|
1
|
5
|
4
|
5
|
8
|
3
|
5
|
3
|
|
Cash |
1
|
0
|
1
|
5
|
4
|
5
|
8
|
3
|
5
|
3
|
|
Cash Equivalents |
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
2
|
0
|
3
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
|
Accounts Receivables |
1
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
2
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
7
|
0
|
5
|
8
|
5
|
7
|
10
|
5
|
6
|
4
|
|
PP&E Net |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
PP&E Gross |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
1
|
0
|
2
|
2
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Intangible Assets |
7
|
7
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
15
N/A
|
0
N/A
|
12
N/A
|
12
+2%
|
6
-51%
|
7
+23%
|
10
+44%
|
5
-53%
|
7
+36%
|
5
-32%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
|
Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
3
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
Total Current Liabilities |
4
|
0
|
2
|
2
|
3
|
1
|
2
|
1
|
1
|
2
|
|
Long-Term Debt |
0
|
0
|
5
|
5
|
6
|
8
|
2
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
9
|
0
|
0
|
0
|
|
Total Liabilities |
4
N/A
|
0
N/A
|
8
N/A
|
9
+6%
|
8
-3%
|
10
+17%
|
14
+42%
|
1
-91%
|
1
-21%
|
2
+144%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Retained Earnings |
5
|
0
|
14
|
20
|
26
|
31
|
47
|
41
|
46
|
50
|
|
Additional Paid In Capital |
19
|
20
|
20
|
26
|
26
|
0
|
0
|
46
|
52
|
53
|
|
Other Equity |
3
|
0
|
3
|
3
|
3
|
28
|
43
|
3
|
3
|
3
|
|
Total Equity |
11
N/A
|
0
N/A
|
4
N/A
|
3
-8%
|
2
N/A
|
2
-2%
|
3
-35%
|
4
N/A
|
6
+56%
|
2
-64%
|
|
Total Liabilities & Equity |
15
N/A
|
0
N/A
|
12
N/A
|
12
+2%
|
6
-51%
|
7
+23%
|
10
+44%
|
5
-53%
|
7
+36%
|
5
-32%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
10
|
0
|
11
|
19
|
19
|
34
|
52
|
64
|
93
|
99
|